In 2005, LLNL researchers won a R&D 100 award for developing advanced technologies to rapidly detect the airborne release of biological threat agents. The Biological Aerosol Mass Spectrometry (BAMS) system is an instrument about the size of three podiums that can analyze individual aerosol particles in real time and at high rates to almost instantly identify the presence and concentration of harmful biological particles in air samples. BAMS was designed for operation in office buildings or at ports of entry such as airports or train stations to monitor for potential epidemic diseases. Biomedical applications could include rapid detection of respiratory diseases such as tuberculosis and coronaviruses.

Multiple issued patents and copyrights (LLNL internal cases # CP01358, CP01357, CP01356, IL10944, IL11492)